Board Membership

The Board Membership team at ARTHEx Biotech is responsible for providing strategic oversight and governance to advance the company's mission of developing AntagomiR oligonucleotides for treating Myotonic Dystrophy. This team collaborates to define the company's direction, ensure compliance with regulations, and leverage their expertise to guide research and development efforts, ultimately aiming to bring innovative therapies to patients.